Literature DB >> 6321166

Concentrations of ampicillin plus sulbactam in serum and intestinal mucosa and effects on the colonic microflora in patients undergoing colorectal surgery.

L Kager, A S Malmborg, S Sjöstedt, C E Nord.   

Abstract

Ampicillin and sulbactam were administered intravenously in 2 g and 1 g doses respectively every 8 h for two days to ten patients undergoing colorectal surgery. Drug concentrations were determined in serum, intestinal mucosa and faeces. The first dose was given at induction of anesthesia. The serum half-life was 2.1 h for ampicillin and 2.0 h for sulbactam on the first day. The concentrations in intestinal mucosa were in most cases 50% or more of the serum concentrations and there was no statistical difference between the two drugs. Faecal concentrations of both drugs were found in eight patients: a mean of 10.5 micrograms/g for ampicillin and a mean of 7.5 micrograms/g for sulbactam. Faecal samples were also collected during the investigation period for culture of aerobic and anaerobic bacteria. Among the aerobic bacteria enterococci, streptococci and enterobacteria decreased markedly during the prophylaxis period. Anaerobic bacteria were also suppressed significantly during the same period. The changes in colonic microflora were related to the concentrations of ampicillin and sulbactam in the intestinal mucosa and faeces. Overgrowth of yeasts was observed in six patients and overgrowth of Pseudomonas fluorescens in two others. These strains were resistant to the combination ampicillin and sulbactam. The microflora normalized in all patients after two weeks. No postoperative infections occurred.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6321166     DOI: 10.1007/bf02016565

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  6 in total

1.  WOUND SEPSIS AFTER CLEAN OPERATIONS.

Authors:  U LJUNGQVIST
Journal:  Lancet       Date:  1964-05-16       Impact factor: 79.321

2.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

3.  Antimicrobial prophylaxis to prevent mixed bacterial infection.

Authors:  B F Polk
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

4.  Comparative inhibition beta-lactamases by novel beta-lactam compounds.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

5.  Effect of clindamycin prophylaxis on the colonic microflora in patients undergoing colorectal surgery.

Authors:  L Kager; L Liljeqvist; A S Malmborg; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

6.  Effects of ampicillin plus sulbactam on bowel flora in patients undergoing colorectal surgery.

Authors:  L Kager; L Liljeqvist; A S Malmborg; C E Nord; R Pieper
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

  6 in total
  5 in total

1.  Comparison of concentrations of sulbactam-ampicillin administered by bolus injections or bolus plus continuous infusion in tissues of patients undergoing colorectal surgery.

Authors:  C Martin; A Cotin; A Giraud; M Beccani-Argème; P Alliot; M N Mallet; M Argème
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

2.  Imipenem concentrations in colorectal surgery and impact on the colonic microflora.

Authors:  L Kager; B Brismar; A S Malmborg; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

3.  Ampicillin plus sulbactam in vitro activity against anaerobes.

Authors:  F Heilmann; W Heizmann; H Werner
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 4.  Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.

Authors:  D M Campoli-Richards; R N Brogden
Journal:  Drugs       Date:  1987-06       Impact factor: 9.546

5.  In vitro activity of ampicillin plus sulbactam against anaerobes compared to ampicillin and cefoxitin.

Authors:  W Heizmann; F Heilmann; H Werner
Journal:  Infection       Date:  1987       Impact factor: 3.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.